Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young
Deep financing challenges separate haves and have-nots and accelerates move to sustainable models
BOSTON, May 5 /PRNewswire/ -- Despite worldwide economic turmoil, the global biotechnology industry delivered a solid financial performance in 2008, according to Beyond borders: Global biotechno...
Physicists discover important step for making light crystals
COLUMBUS, Ohio -- Ohio State University researchers have developed a new strategy to overcome one of the major obstacles to a grand challenge in physics.
What they've discovered could eventually aid high-temperature superconductivity, as well as the development of new high-tech materials.
Patent for Making Combination Chemotherapy Work Better
SAN JOSE, Calif., March 24 /PRNewswire/ -- Patent 7,507,704 issued on 03/24/09 to NexGen Biomedical, Inc. founder Mark Zamoyski of San Jose, California discloses an improved method of treating lung, brain, pancreatic, breast and colon cancers that are driven by a mutation known as HER1 overexpress...
'Nanonet' circuits closer to making flexible electronics reality
WEST LAFAYETTE, Ind. - Researchers have overcome a major obstacle in producing transistors from networks of carbon nanotubes, a technology that could make it possible to print circuits on plastic sheets for applications including flexible displays and an electronic skin to cover an entire aircraft...
Controlling the size of nanoclusters: First step in making new catalysts
UPTON, NY Researchers from the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and Stony Brook University have developed a new instrument that allows them to control the size of nanoclusters groups of 10 to 100 atoms with atomic precision. They created a model nanocatalyst of m...
Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
- Human Trials to Begin Later This Year - Only Nasal Powder Bird Flu Vaccine Under Development - Patient-Friendly (No Needles); No Preservatives - Stable at Room Temperature For 3 Years; No Cold Chain Distribution Required
Creating the Bionic Woman: Making Nerves Spring Back to Life
Cutting-Edge Nerve Repair Discussed at American Society of Plastic Surgeons Annual Meeting
BALTIMORE, Oct. 28 /PRNewswire-USNewswire/ -- With the debut of NBC's
"Bionic Woman," the notion of a bionic person is thought of as merely
television fantasy. However, the bion...
Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI
WASHINGTON, Oct. 19 /PRNewswire/ -- Interventional cardiologists
operate in an environment of great flux, and as such face many challenges
in the provision of optimal patient care. New devices, continuing debate
over the use of drug-eluting versus bare metal stents, and evolving
Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
Novartis Takes Top Spot, Previously Held by GlaxoSmithKline Since June 2006
PHILADELPHIA and LONDON, Oct. 16 /PRNewswire-FirstCall/ -- Thomson
Scientific, part of The Thomson Corporation (NYSE: TOC ; TSX: TOC) and
leading provider of information solutions to the worldwide research and
Secure Symbology: Making New Jersey Proud While Saving Lives
WAYNE, N.J., Oct. 9 /PRNewswire/ -- A homegrown New Jersey company is
earning accolades for its anti-counterfeiting technology that safeguards
the pedigree of pharmaceuticals everywhere. Secure Symbology
(http://www.securesymbology.com ), a Wayne, NJ based company has been chosen as an
Brain research shows past experience is invaluable for complex decision making
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have shown that past experience really does help when we have to make complex decisions based on uncertain or confusing information. They show that learning from experience actually changes the circuitry in ou...
The Making of Chicago as a Biotech Cluster
On May 15, I had the opportunity to attend an exciting Chicago networking event that was organized by Women Advancing Biosciences . The event featured a presentation by professor Alicia Loffler, who is the director of the Kellog Center for Biotechnology at Northwestern University .
From the back roads to the superhighway: Making the connection to Internet2
A joint effort of industry, government, and more than 200 universities (including the University of Wisconsin-Madison, UW-Milwaukee and Marquette University), Internet2 is leading the way toward revolutionary new network technologies and high-speed Internet-based applications. But effective access...
Modine explores making components for fuel cell vehicles
Milwaukee Modine Manufacturing Company in Racine is providing heat-transfer components for new fuel-cell vehicles developed by Volskwagen Inc. , the company said on Wednesday.
The parts are for use in the Touran HyMotion, the automotive company's new hybrid vehicle. Modine's mass heat tra...
Four steps to making talent management a core competence
According to a study reported in the June 2005 issue of the Harvard Business Review, 'people-driven' businesses are now predominant. But many companies, even in people businesses, don't yet have the talent management processes they need to excel. While organizations have perfected sophisticated t...
Fusion 2006 symposium focuses on making IT work for businesses
Madison, Wis. If the Fusion 2006 CEO-CIO Symposium is anything like last year's event, next Wednesday and Thursday will see the Fluno Center filled with top business and technology executives from all different places but asking the same questions.
"CEOs and CIOs need one another, and need...
Mirus announces new method for making antibodies
Madison, Wis. Mirus Bio Corporation says its scientists have developed a way to make antibodies faster and more cheaply.
Antibodies, naturally part of the immune system, are manufactured both for the treatment of diseases and for diagnostics or research. Mirus' new technique, described in t...
9 tips for making 90 seconds count in an investment pitch
Madison, Wis. -You're in an elevator next to a venture capitalist who could invest millions in your business but doesn't know the first thing about it yet.
You have 90 seconds to explain, starting now.
That's the premise of the Elevator Pitch Olympics, a yearly event at the Wisconsin Earl...
Fusion 2007: Making the business case for technology
Madison, Wis . - Information technology decisions can be made in a vacuum, or as part of an IT-business alignment process, but companies that treat IT as a frills part of the organization are more likely to suffer expensive failures, according to information technology executives attending the 200...
New Tools for Making and Processing Protein Microarrays.
By Linda E. Cammish, Ph.D., NextGen Sciences, Ltd. and Mark N. Bobrow, Ph.D., PerkinElmer Life Sciences, Inc.
The use of DNA microarrays in scientific research and drug discovery has become very widespread. However, since it is proteins and n...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
...o date, approximately 11 million TAXUS stents have been implanted globally, making
them the world's most frequently used coronary stents.
Royalty revenue de...t may reduce the potential for filter migration after implantation, thereby making
the product safer for patients, insertion potential through either the femo...
Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making
cancer more treatable. For additional information, please visit www.CellTherapeutics.com .
This press release includes forward-looking stat...
The Breast Cancer Therapeutics Market in Australia
...be used widely for now. This may be attributed to the fact that the use of targeted therapy is limited due to access and affordability issues, thereby making
those complements rather than substitutes for chemotherapy. "Due to higher cost compared to cytotoxic and hormonal therapies, the use of targeted ther...
New clues about a hydrogen fuel catalyst
...ed the team to outline the chemical reaction occurring between the catalyst and the ammonia borane. The catalyst does not remain still, said Rousseau, making
it a good catalyst but, like an active two-year old, also a difficult subject to pin down.
Plucking Atoms One at a Time
The results suggested ...
ADVENTRX Pharmaceuticals Announces Financing
...ficient stockholders' equity or a sufficient stock price; the risk that the provisions of Delaware General Corporation Law will prohibit ADVENTRX from making
the dividend and other payments due its 5% Series C convertible preferred stock (or to the holders thereof), which may be a breach of its certificate ...
ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery
...ce the delivery of polynucleotide-based antigens and SiRNA to lymph nodes. IVT has proven its scale-up capabilities at a contract manufacturing plant, making
DepoVax(TM) amenable to commercialization.
ImmunoVaccine Technologies continues to strengthen its vaccine pipeline through licensing and strategi...
Plastics that convert light to electricity could have a big impact
...ether polymers they are working with are ever likely to reach the 10 percent efficiency threshold.
Making solar cells more efficient is crucial to making
them cost effective, he said. And if costs can be brought low enough, solar cells could offset the need for more coal-generated electricity in years t...
Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
...resident and Chief Executive Officer of Genomic Health. "Our continued growth and strong financial position support the substantial investment we are making
to develop and commercialize additional tests to personalize the treatment of cancer. Since 2004, we have delivered Onco type DX to more than 100,00...
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
...he new agreement with Firmenich. Based upon this development, Senomyx is updating our guidance for net cash used in operating activities. We are not making
any changes to the remainder of our financial guidance for 2009," Poyhonen stated.
For the full year 2009, Senomyx now expects:
ETC Biomedical Announces Chamber Sale in India
...enable technicians to focus their attention on patient care and management, making
your team more effective and efficient.
ETC chambers remain the lea... Business." Shareholders are urged to review these risks carefully prior to making
an investment in the Company's common stock.
The Company cautions ...
OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
... of OmniComm," said Simon Kemp, Logos Technology Ltd.'s Managing Director. "OmniComm's team of industry professionals was a key factor in our decision making
process. We have worked closely with OmniComm in the past with several joint clients and see this as an opportunity to enhance and fully integrate th...
Cardinal Health Completes Biotech Acquisition
..., physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making
supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops mark...
Model predicts evolution of Mediterranean landscape following fires
...t, this research study is part of a broader study into changes in soil use in rural areas, and will be incorporated into other models to help decision making
about land use in these areas.
Cellular automata to represent fire
"We used 'cellular automata' to represent how fires spread, bearing in mind t...
CuraGen Reports Second Quarter 2009 Financial Results
....com . Investors are urged to read the Joint Proxy Statement/Prospectus/prospectus and the other relevant materials when they become available before making
any voting or investment decision with respect to the merger.
Participants in the Solicitation
The directors and executive officers of Cell...
Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
...E URGED TO READ THE PROXY STATEMENT CAREFULLY WHEN IT IS AVAILABLE, AS IT WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD CONSIDER BEFORE making
A DECISION ABOUT APPROVING AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES.
In addition ...
Biopolymers Symposium 2009 Teams with Carbonfund.org to Create a Zero-Carbon Event
...ctive Brochure or visiting www.biopolymersummit.com and learn more about making
the event carbon neutral by visiting www.carbonfund.org .
"As par... is the leading nonprofit carbon offset and climate solutions organization, making
it easy and affordable for individuals, businesses and organizations to red...
Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference
...argeted therapeutics have emerged as the next frontier in the fight against cancer. As such, this field is significantly influencing current decision making
with respect to oncology drug development. With this in mind, Dr. Bergstein's presentation will cover novel pre-clinical and clinical development par...
Breaking barriers with nanoscale lasers
...nications devices, single molecule detection and medical imaging."
Nanoscale lasers can also be integrated with other biomedical diagnostic tools, making
them work faster and more efficiently, he says.
These advances also represent a major step in nanophotonics the study of the behavior of light on ...
Seasoned Dermatologist Nissan Pilest of Irvine, CA, Joins SDS Clinical Trials as Clinical Investigator for Dermatology Division
... fortunate to have such an esteemed physician to participate in our forthcoming trials."
Dr. Pilest treats a multi-ethnic patient population, making
him perfectly situated to be able to select a true cross section of patients who may qualify for the various clinical trials launched through SDS.
GreenHouse Debuts the World's First E-Fuel MicroFuelerTM in Los Angeles
...th quarter of 2009 and is now taking preorders for the unit. "With the launch of the first operational MicroFueler in Los Angeles, GreenHouse is making
consumer-use of E-Fuel100 an option for people who want to gain control over vehicle fuel costs and take active steps towards improving the environmen...